Symbol="CSBR"
AssetType="Common Stock"
Name="Champions Oncology Inc"
Description="Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. The company is headquartered in Hackensack, New Jersey."
CIK="771856"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, US"
FiscalYearEnd="April"
LatestQuarter="2023-01-31"
MarketCapitalization="89628000"
EBITDA="-815000"
PERatio="None"
PEGRatio="0"
BookValue="0.521"
DividendPerShare="0"
DividendYield="0"
EPS="-0.23"
RevenuePerShareTTM="3.985"
ProfitMargin="-0.0581"
OperatingMarginTTM="-0.0568"
ReturnOnAssetsTTM="-0.0546"
ReturnOnEquityTTM="-0.383"
RevenueTTM="53676000"
GrossProfitTTM="25477000"
DilutedEPSTTM="-0.23"
QuarterlyEarningsGrowthYOY="-0.286"
QuarterlyRevenueGrowthYOY="-0.032"
AnalystTargetPrice="9.5"
TrailingPE="-"
ForwardPE="43.48"
PriceToSalesRatioTTM="1.379"
PriceToBookRatio="9.83"
EVToRevenue="1.733"
EVToEBITDA="38.29"
Beta="0.902"
num_52WeekHigh="9.88"
num_52WeekLow="3.75"
num_50DayMovingAverage="5.53"
num_200DayMovingAverage="5.43"
SharesOutstanding="13558600"
DividendDate="None"
ExDividendDate="None"
symbol="CSBR"
open="6.77"
high="6.79"
low="6.61"
price="6.61"
volume="7021.00"
latest_trading_day="2023-07-14"
previous_close="6.81"
change="-0.20"
change_percent="-2.9310%"
aroon_positive_momentum_days="68"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="10718"
Change_recent_avg="0.03"
Delta_recent_avg="0.22"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="0.42"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="1128"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0161.jpeg"
image_negative_thumbnail_id_2="1160"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="961"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_positive_thumbnail_id_2="622"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
